The increasing frequency and severity of environmental disasters necessitate robust health-care system adaptation strategies. Recent wildfire events in and around Los Angeles County, CA, USA, are ...
NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback